Skip to main content

Peer Review reports

From: A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients

Original Submission
31 Aug 2017 Submitted Original manuscript
14 Sep 2017 Author responded Author comments - Anne-Laure Giraudet
Resubmission - Version 2
14 Sep 2017 Submitted Manuscript version 2
14 Nov 2017 Reviewed Reviewer Report - Robert Canter
30 Nov 2017 Reviewed Reviewer Report - Seth M. Pollack
4 Jan 2018 Author responded Author comments - Anne-Laure Giraudet
Resubmission - Version 3
4 Jan 2018 Submitted Manuscript version 3
4 Feb 2018 Reviewed Reviewer Report - Seth M. Pollack
5 Apr 2018 Author responded Author comments - Anne-Laure Giraudet
Resubmission - Version 4
5 Apr 2018 Submitted Manuscript version 4
Publishing
21 May 2018 Editorially accepted
8 Jun 2018 Article published 10.1186/s12885-018-4544-x

You can find further information about peer review here.

Back to article page